Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.

[This corrects the article DOI: 10.1371/journal.pone.0184550.].

Bibliographic Details
Main Authors:	María Buti, María L Manzano, Rosa M Morillas, Montserrat García-Retortillo, Leticia Martín, Martín Prieto, María L Gutiérrez, Emilio Suárez, Mariano Gómez Rubio, Javier López, Pilar Castillo, Manuel Rodríguez, José M Zozaya, Miguel A Simón, Luis E Morano, José L Calleja, María Yébenes, Rafael Esteban
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2018-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC6016912?pdf=render

id	doaj-4c0a108992164a83bd464ee6c571e8f3
record_format	Article
spelling	doaj-4c0a108992164a83bd464ee6c571e8f32020-11-25T01:46:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01136e019992610.1371/journal.pone.0199926Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.María ButiMaría L ManzanoRosa M MorillasMontserrat García-RetortilloLeticia MartínMartín PrietoMaría L GutiérrezEmilio SuárezMariano Gómez RubioJavier LópezPilar CastilloManuel RodríguezJosé M ZozayaMiguel A SimónLuis E MoranoJosé L CallejaMaría YébenesRafael Esteban[This corrects the article DOI: 10.1371/journal.pone.0184550.].http://europepmc.org/articles/PMC6016912?pdf=render
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	María Buti María L Manzano Rosa M Morillas Montserrat García-Retortillo Leticia Martín Martín Prieto María L Gutiérrez Emilio Suárez Mariano Gómez Rubio Javier López Pilar Castillo Manuel Rodríguez José M Zozaya Miguel A Simón Luis E Morano José L Calleja María Yébenes Rafael Esteban
spellingShingle	María Buti María L Manzano Rosa M Morillas Montserrat García-Retortillo Leticia Martín Martín Prieto María L Gutiérrez Emilio Suárez Mariano Gómez Rubio Javier López Pilar Castillo Manuel Rodríguez José M Zozaya Miguel A Simón Luis E Morano José L Calleja María Yébenes Rafael Esteban Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study. PLoS ONE
author_facet	María Buti María L Manzano Rosa M Morillas Montserrat García-Retortillo Leticia Martín Martín Prieto María L Gutiérrez Emilio Suárez Mariano Gómez Rubio Javier López Pilar Castillo Manuel Rodríguez José M Zozaya Miguel A Simón Luis E Morano José L Calleja María Yébenes Rafael Esteban
author_sort	María Buti
title	Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
title_short	Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
title_full	Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
title_fullStr	Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
title_full_unstemmed	Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
title_sort	correction: randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis b virus reactivation in anti-hbc-positive patients with rituximab-based regimens to treat hematologic malignancies: the preblin study.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2018-01-01
description	[This corrects the article DOI: 10.1371/journal.pone.0184550.].
url	http://europepmc.org/articles/PMC6016912?pdf=render
work_keys_str_mv	AT mariabuti correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT marialmanzano correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT rosammorillas correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT montserratgarciaretortillo correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT leticiamartin correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT martinprieto correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT marialgutierrez correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT emiliosuarez correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT marianogomezrubio correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT javierlopez correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT pilarcastillo correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT manuelrodriguez correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT josemzozaya correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT miguelasimon correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT luisemorano correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT joselcalleja correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT mariayebenes correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy AT rafaelesteban correctionrandomizedprospectivestudyevaluatingtenofovirdisoproxilfumarateprophylaxisagainsthepatitisbvirusreactivationinantihbcpositivepatientswithrituximabbasedregimenstotreathematologicmalignanciesthepreblinstudy
_version_	1725020650157899776

Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.

Similar Items